The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
26005026 |
25 |
Synthesis, characterization, hypoglycemic and aldose reductase inhibition activity of arylsulfonylspiro[fluorene-9,5'-imidazolidine]-2',4'-diones. |
Quaid-I-Azam University |
24819954 |
16 |
Structure-activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents. |
University of Messina |
40025 |
4 |
Nicotinamide adenine dinucleotide phosphate-decanaldehyde adduct as an inhibitor of beef brain NADP-linked aldehyde reductase. |
TBA |
23683835 |
21 |
Synthesis of organic nitrates of luteolin as a novel class of potent aldose reductase inhibitors. |
Xiangtan University |
20452228 |
13 |
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. |
University of Messina |
18492610 |
9 |
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives. |
Universit£ |
17512196 |
8 |
Evaluation of in vitro aldose redutase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. |
Universit£ |
11356107 |
16 |
Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis. |
Sankyo |
10354396 |
32 |
1-Benzopyran-4-one antioxidants as aldose reductase inhibitors. |
Universit£ |
8893834 |
30 |
Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors. |
TBA |
8027986 |
30 |
Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1. |
Wyeth-Ayerst Research |
3121857 |
128 |
Spiro hydantoin aldose reductase inhibitors. |
Pfizer |
21531055 |
14 |
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications. |
Universit£ |
21129963 |
23 |
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. |
University of Messina |
20395149 |
11 |
Synthesis, characterization and vasculoprotective effects of nitric oxide-donating derivatives of chrysin. |
Central South University |
| 3 |
Structure-based design of an inhibitor modeled at the substrate active site of aldose reductase |
TBA |
10354397 |
28 |
Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors. |
Dipartimento Di Scienze Farmaceutiche |
9822541 |
15 |
Synthesis, activity, and molecular modeling of new 2, 4-dioxo-5-(naphthylmethylene)-3-thiazolidineacetic acids and 2-thioxo analogues as potent aldose reductase inhibitors. |
Ep811-Cnrs |
8027987 |
1 |
N-substituted spirosuccinimide, spiropyridazine, spiroazetidine, and acetic acid aldose reductase inhibitors derived from isoquinoline-1,3-diones. 2. |
Wyeth-Ayerst Research |
6818344 |
15 |
Spiro oxazolidinedione aldose reductase inhibitors. |
TBA |
6422042 |
3 |
N-[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]- N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor. |
TBA |
3934383 |
6 |
Synthesis, absolute configuration, and conformation of the aldose reductase inhibitor sorbinil. |
TBA |
2539477 |
5 |
Computer-assisted design and synthesis of novel aldose reductase inhibitors. |
Wyeth-Ayerst Research |
2120443 |
1 |
(Pyrimidinyloxy)acetic acids and pyrimidineacetic acids as a novel class of aldose reductase inhibitors. |
Wyeth-Ayerst Research |
1908522 |
5 |
Syntheses of tolrestat analogues containing additional substituents in the ring and their evaluation as aldose reductase inhibitors. Identification of potent, orally active 2-fluoro derivatives. |
Wyeth-Ayerst Research |
1901912 |
1 |
Quinazolineacetic acids and related analogues as aldose reductase inhibitors. |
Wyeth-Ayerst Research |